上呼吸道感染的治疗体会  

The Treatment Experience of Upper Respiratory Tract Infection

作　　者：姜淼[1] 刘爽[1] 郑宇静[1] 左炳会 吕海波[1] 

机构地区：[1]大庆油田总医院集团脑血管医院,163411

出　　处：《中国卫生标准管理》2015年第3期158-159,共2页China Health Standard Management

摘　　要：目的探讨治疗上呼吸道感染药物的疗效及不良反应。方法将我院收治的30例上呼吸道感染患者,按照入院病理号码(基数和偶数),分成试验组和对比组,每组15例,试验组采用双黄连药物治疗,对比组采用阿奇霉素+利巴韦林注射液治疗,治疗一个疗程(7天)后观察效果。结果试验组疗效优于对比组,两组对比有差异P<0.05。结论采用双黄连药物治疗上呼吸道感染,有效防止疾病进一步发展,提高治疗疗效。Objective The efficacy and side-effects of medical treatment in upper respiratory tract infection is to be discussed. Methods Choose 30 patients with upper respiratory tract infection are to treated in hospital,separate them into study group and control group,according to patients’number when they are hospitalized （cardinal number and even number）,each group has 15 patients,patients in study group are given Shuanghuanglian medicine,while patients in control group are given azithromycin and ribavirin injection therapy,and then observe and compare the treatment effects of the two groups after one-week （7 days） treatment. Results The treatment efficacy of study group is much more favorable than control group,there is an efficacy differential between two groups,P〈0.05. Conclusion Shuanghuanglian medicine is quite effective to cure upper respiratory tract infection and prevent from the illness degeneration,and improve the medicine efficacy.

关 键 词：上呼吸道感染 治疗 不良反应 

分 类 号：R562[医药卫生—呼吸系统]